Back to search

Article

Pharmacogenomics of hypertension in chronic kidney disease: the CKD-PGX study

2021-04-06

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Patients with chronic kidney disease (CKD) often have uncontrolled hypertension despite polypharmacy. Pharmacogenomic drug-gene interactions (DGIs) may impact the metabolism or efficacy of antihypertensive agents. We hypothesized that providing a panel of 11 pharmacogenomic predictors of antihypertensive response would improve hypertension control. <h4>Methods</h4> A prospecti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
30e0ba17-c532-5164-9ec2-ab0b39c251f9
DOI
10.1101/2021.03.30.21254665
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacogenomics of hypertension in chronic kidney disease: the CKD-PGX studyDOI 10.1101/2021.03.30.21254665
Hypertension precision medicine: the promise and pitfalls of pharmacogenomicsSemantic proximity
Pharmacogenomics And Hypertension: Current InsightsSemantic proximity
Pharmacogenomics in Hypertension: Where We Stand TodaySemantic proximity
Cardiometabolic drugs and kidney function – a drug target Mendelian randomisation studySemantic proximity
Renin^|^ndash;Angiotensin System, Hypertension, and Chronic Kidney Disease: Pharmacogenetic ImplicationsSemantic proximity
Pharmacogenetics of antihypertensive treatment.Semantic proximity
Advancing management of hypertension through pharmacogenomicsSemantic proximity
Beyond Blood Pressure: Emerging Pathways and Precision Approaches in Hypertension-Induced Kidney DamageSemantic proximity
Use of drugs with Pharmacogenomics (PGx)-Based Dosing Guidelines in a Danish Cohort of Persons with Chronic Kidney Disease, Both on Dialysis and Not on Dialysis: Perspectives for Prescribing OptimizationSemantic proximity
Cardiovascular Pharmacogenomics--Implications for Patients With CKD.Semantic proximity
Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.Semantic proximity
The Use of Genomics to Drive Kidney Disease Drug Discovery and Development.Semantic proximity
Select a neighboring publication to make it the new centre.